| Product NDC: | 60055-018 |
| Proprietary Name: | Sodium Fluoride F 18 |
| Non Proprietary Name: | Sodium Fluoride F-18 |
| Active Ingredient(s): | 475 mCi/mL & nbsp; Sodium Fluoride F-18 |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60055-018 |
| Labeler Name: | Triad Isotopes, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20101120 |
| Package NDC: | 60055-018-30 |
| Package Description: | 30 mL in 1 VIAL (60055-018-30) |
| NDC Code | 60055-018-30 |
| Proprietary Name | Sodium Fluoride F 18 |
| Package Description | 30 mL in 1 VIAL (60055-018-30) |
| Product NDC | 60055-018 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sodium Fluoride F-18 |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101120 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Triad Isotopes, Inc. |
| Substance Name | SODIUM FLUORIDE F-18 |
| Strength Number | 475 |
| Strength Unit | mCi/mL |
| Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |